Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron

Cell Reports(2022)10.1016/j.celrep.2022.110799Source: DataRank Database

Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 70 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access70 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 6.66)OA: goldTopics (25)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Courtney E. Karl ORCID,Peter Halfmann ORCID,Yoshihiro Kawaoka ORCID,Emma S. Winkler ORCID,Shamus P. Keeler ORCID

Live enrichment

PubMed:35523172 OpenAlex:https://openalex.org/W4224240133

National Institutes of Health

Grant: F30 AI152327

National Institutes of Health

Grant: R35 HL145242

National Institutes of Health

Grant: R01 AI157155

National Institutes of Health

Grant: 75N93021C00014

National Institutes of Health

Grant: 75N93019C00051

National Institutes of Health

Grant: U01 AI151810

National Institutes of Health

Grant: T32GM139774-01

FWCI

6.66

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124722005666/pdf

publisherhttp://www.cell.com/article/S2211124722005666/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124722005666?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124722005666?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2022.110799

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesRespiratory viral infections research

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAnimalsAntiviral AgentsHumansInterferonsMice, TransgenicMice

Keywords

Monoclonal antibodyInterferonVirologyAntibodyCytokineCoronavirusImmunologyVirusBiologyRespiratory systemSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineCoronavirus disease 2019 (COVID-19)

Sustainable Development Goals

SDG 0: Good health and well-being